Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Princess Margaret Hospital and University of Toronto, Canada

Share :

ESMO 33

12 - 16 Sep 2008
Published: 28 Nov 2008
Views: 14953
Rating:
Save
Prof. Ian Tannock
Patupilone in patients with metastatic hormone refractory prostate cancer who have progressed after docetaxel, from ESMO 2008

Related Videos

OncoAlert Round Up for September 15-21, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 15-21, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
OncoAlert Round Up for September 8-14, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for September 8-14, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
25 Sep 2023
OncoAlert Round Up for August 11th - 17th, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert Round Up for August 11th - 17th, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
22 Aug 2023
OncoAlert round up July 28th to August 3rd, 2023
Dr Gil Morgan - Executive Director, OncoAlert
OncoAlert round up July 28th to August 3rd, 2023 ( Dr Gil Morgan - Executive Director, OncoAlert )
4 Aug 2023
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of...
Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina
The iCCaRE Consortium for Black Men - Addressing the disproportionate burden of prostate cancer ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )
28 Jun 2023
Radiation therapy after radical surgery in prostate cancer
Dr Roberto Paz - Oncosalud - AUNA, Lima, Peru
Radiation therapy after radical surgery in prostate cancer ( Dr Roberto Paz - Oncosalud - AUNA, Lima, Peru )
22 Jun 2023
iCCaRE Consortium for Black Men: Second Discussion
Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina
iCCaRE Consortium for Black Men: Second Discussion ( Mr Arnold Merriweather, Dr Che Ngufor and Dr Folakemi Odedina )
8 Jun 2023
ASCO 2023: Highlights and analysis
Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2023: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )
6 Jun 2023

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation